Kash’s Corner: Sam Bankman-Fried Bribed CCP Officials With Over $40 Million; Moderna’s $400 Million ‘Kickback’ to NIH Scientists?
Kash's Corner
Kash Patel
4.8 • 627 Ratings
🗓️ 1 April 2023
⏱️ 32 minutes
🧾️ Download transcript
Summary
The National Institute of Allergy and Infectious Diseases (NIAID), which is part of the NIH, received $400 million from Moderna in a “catch-up payment,” according to a newly disclosed contract that The Epoch Times obtained through a Freedom of Information Act request.
So where is the money going? Which government officials are getting the money?
Kash Patel argues that it poses a major conflict of interest for scientists at the NIH to be able to receive royalties from patents.
“Do people in the Department of Agriculture who work with private-sector farmers and come up with some new seed receive millions of dollars from the farming industry? No,” Patel said.
“What about the army guy that comes up with the technology for our next aerial asset, [and] we enter into a contract with Lockheed Martin or Boeing to make billions of dollars worth of this? Is he going to get a royalty from that? Absolutely not,” he said.
The NIH received up to $2 billion in royalties from 34 drug contracts between 1991 and 2019, according to a report from the U.S. Government Accountability Office.
We also take a look at new allegations of bribery in FTX founder Sam Bankman-Fried’s case. On top of the 12 counts he was already indicted on, he’s now being charged for allegedly bribing Chinese officials to the tune of over $40 million to get his accounts in China unfrozen.
Follow EpochTV on social media:
Twitter: https://twitter.com/EpochTV
Rumble: https://rumble.com/c/EpochTV
Truth Social: https://truthsocial.com/@EpochTV
Gettr: https://gettr.com/user/epochtv
Facebook: https://www.facebook.com/EpochTVus
Gab: https://gab.com/EpochTV
Telegram: https://t.me/EpochTV
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hey everybody and welcome back to Cash's Corner. Jan, we have an interesting episode today, |
| 0:15.8 | some quickfire subjects and some long-term subjects. Where do you want to start? |
| 0:19.5 | Authorization for use of military force. |
| 0:22.4 | The Senate has just passed the rescinding of it for Iraq. |
| 0:25.3 | This has some pretty incredible implications if it actually goes through to the end. |
| 0:30.4 | So we definitely want to touch that on that. |
| 0:32.6 | Sam Bankman-Fried, a new indictment fascinating. |
| 0:35.4 | But the big thing I really want to talk about is this |
| 0:38.5 | 400 million that we've discovered, Moderna, you know, paid out in the not too distant past |
| 0:45.6 | to NIH, to NIH, to NIAID, actually, Fauci is at the time agency. |
| 0:50.6 | Yeah, that's a lot. So we'll try to simplify it. So AUMF, the authorization of use of military force, we call the AUMF. |
| 1:00.0 | Legally, Congress has to act under the law every time the United States commits its military to a theater of war for operational purposes. That's the law. |
| 1:13.8 | If we go to war, Congress must act. That's a very oversimplification. But that's what the |
| 1:18.6 | AUMF is for. The Defense Department or the United States government goes to Congress or the |
| 1:24.4 | president usually and says, hey, I want to conduct operations in X. |
| 1:28.5 | I'll give you an example. |
| 1:29.4 | 9-11 occurs, right? |
| 1:31.2 | The attacks on the World Trade Center, the Pentagon, and in Pennsylvania. |
| 1:34.3 | Very swiftly after that, in order to invade Afghanistan, Congress passed a resolution, a law, |
| 1:41.2 | the AUMF, the authorization of use of military force to hunt terrorists in Afghanistan |
| 1:47.5 | responsible for the 9-11 attacks. Now, what's supposed to happen is every time you enter |
| 1:53.6 | a new theater of war, a new area of operational review, as we call it, you're supposed to do |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Kash Patel, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Kash Patel and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.